TEL AVIV, Israel, Feb. 10, 2026 /PRNewswire/ -- Protai, www.protai.bio, an AI drug discovery startup, announced its participation in a series of major scientific conferences this spring, where it will present significant advances in its AIMS™ proteomics-aware-AI drug discovery platform...
Hence then, the article about protai to showcase groundbreaking aims drug discovery platform and best in class prt001 kat6a degrader results at spring 2026 global conferences was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Protai to showcase groundbreaking AIMS™ drug discovery platform and best-in-class PRT001 KAT6A degrader results at spring 2026 global conferences. )
Also on site :
- ELEGOO kündigt die weltweite Markteinführung des Jupiter 2 an und präsentiert auf der RAPID + TCT 2026 das Mehrfarben-System für Centauri Carbon
- Zimbabwe: Tragedy On Bulawayo-Beitbridge Road - 18 Die in Kombi Inferno
- Xinhua Silk Road: Ningbo and China's shift from making things to making them smarter